Checkpoint Therapeutics Inc (CKPT)
2.03
+0.15
(+7.98%)
USD |
NASDAQ |
May 20, 16:00
2.03
0.00 (0.00%)
After-Hours: 07:49
Checkpoint Therapeutics Cash from Financing (TTM): 46.43M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 46.43M |
December 31, 2023 | 40.45M |
September 30, 2023 | 37.35M |
June 30, 2023 | 29.26M |
March 31, 2023 | 15.35M |
December 31, 2022 | 14.89M |
September 30, 2022 | 12.01M |
June 30, 2022 | 12.54M |
March 31, 2022 | 22.70M |
December 31, 2021 | 40.27M |
September 30, 2021 | 39.94M |
June 30, 2021 | 63.42M |
March 31, 2021 | 55.22M |
December 31, 2020 | 31.25M |
September 30, 2020 | 45.32M |
Date | Value |
---|---|
June 30, 2020 | 23.64M |
March 31, 2020 | 25.04M |
December 31, 2019 | 25.46M |
September 30, 2019 | 7.709M |
June 30, 2019 | 12.13M |
March 31, 2019 | 8.085M |
December 31, 2018 | 28.58M |
September 30, 2018 | 28.58M |
June 30, 2018 | 20.82M |
March 31, 2018 | 20.84M |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | -2.222M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
7.709M
Minimum
Sep 2019
63.42M
Maximum
Jun 2021
30.02M
Average
27.36M
Median
Cash from Financing (TTM) Benchmarks
QuidelOrtho Corp | -224.70M |
Fortress Biotech Inc | 38.41M |
Anavex Life Sciences Corp | 18.40M |
Ocugen Inc | 15.24M |
NovaBay Pharmaceuticals Inc | 1.313M |